Literature DB >> 34156448

ReMeDy: a platform for integrating and sharing published stem cell research data with a focus on iPSC trials.

Kirill Borziak1, Irena Parvanova1, Joseph Finkelstein1.   

Abstract

ABSTRACT: Recent regenerative medicine studies have emphasized the need for increased standardization, harmonization and sharing of information related to stem cell product characterization, to help drive these innovative interventions toward public availability and to increase collaboration in the scientific community. Although numerous attempts and numerous databases have been made to manage these data, a platform that incorporates all the heterogeneous data collected from stem cell projects into a harmonized project-based framework is still lacking. The aim of the database, which is described in this study, is to provide an intelligent informatics solution that integrates comprehensive characterization of diverse stem cell product characteristics with research subject and project outcome information. In the resulting platform, heterogeneous data are validated using predefined ontologies and stored in a relational database, to ensure data quality and ease of access. Testing was performed using 51 published, publically available induced pluripotent stem cell projects conducted in clinical, preclinical and in-vitro evaluations. Future aims of this project include further increasing the database size to include all published stem cell trials and develop additional data visualization tools to improve usability. Our testing demonstrated the robustness of the proposed platform, by seamlessly harmonizing diverse common data elements, and the potential of this platform for driving knowledge generation from the aggregation and harmonization of these diverse data. DATABASE URL: https://remedy.mssm.edu/.
© The Author(s) 2021. Published by Oxford University Press.

Entities:  

Mesh:

Year:  2021        PMID: 34156448      PMCID: PMC8218701          DOI: 10.1093/database/baab038

Source DB:  PubMed          Journal:  Database (Oxford)        ISSN: 1758-0463            Impact factor:   4.462


  54 in total

1.  Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.

Authors:  Atsutaka Minagawa; Toshiaki Yoshikawa; Masaki Yasukawa; Akitsu Hotta; Mihoko Kunitomo; Shoichi Iriguchi; Maiko Takiguchi; Yoshiaki Kassai; Eri Imai; Yutaka Yasui; Yohei Kawai; Rong Zhang; Yasushi Uemura; Hiroyuki Miyoshi; Mahito Nakanishi; Akira Watanabe; Akira Hayashi; Kei Kawana; Tomoyuki Fujii; Tetsuya Nakatsura; Shin Kaneko
Journal:  Cell Stem Cell       Date:  2018-11-15       Impact factor: 24.633

2.  GMP-compatible manufacturing of three iPS cell lines from human peripheral blood.

Authors:  Alexandra Haase; Wolfgang Glienke; Lena Engels; Gudrun Göhring; Ruth Esser; Lubomir Arseniev; Ulrich Martin
Journal:  Stem Cell Res       Date:  2019-02-11       Impact factor: 2.020

3.  Activity in grafted human iPS cell-derived cortical neurons integrated in stroke-injured rat brain regulates motor behavior.

Authors:  Sara Palma-Tortosa; Daniel Tornero; Marita Grønning Hansen; Emanuela Monni; Mazin Hajy; Sopiko Kartsivadze; Sibel Aktay; Oleg Tsupykov; Malin Parmar; Karl Deisseroth; Galyna Skibo; Olle Lindvall; Zaal Kokaia
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-06       Impact factor: 11.205

4.  Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.

Authors:  Ryota Tabei; Shinji Kawaguchi; Hideaki Kanazawa; Shugo Tohyama; Akinori Hirano; Noriko Handa; Shuji Hishikawa; Takumi Teratani; Satoshi Kunita; Junichi Fukuda; Yoshihiro Mugishima; Tsuneyoshi Suzuki; Kazuaki Nakajima; Tomohisa Seki; Yoshikazu Kishino; Marina Okada; Masataka Yamazaki; Kazuma Okamoto; Hideyuki Shimizu; Eiji Kobayashi; Yasuhiko Tabata; Jun Fujita; Keiichi Fukuda
Journal:  J Heart Lung Transplant       Date:  2018-11-15       Impact factor: 10.247

5.  KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.

Authors:  Hiroshi Kohara; Taiju Utsugisawa; Chika Sakamoto; Lisa Hirose; Yoshie Ogawa; Hiromi Ogura; Ai Sugawara; Jiyuan Liao; Takako Aoki; Takuya Iwasaki; Takayoshi Asai; Sayoko Doisaki; Yusuke Okuno; Hideki Muramatsu; Takaaki Abe; Ryo Kurita; Shohei Miyamoto; Tetsushi Sakuma; Masayuki Shiba; Takashi Yamamoto; Shouichi Ohga; Kenichi Yoshida; Seishi Ogawa; Etsuro Ito; Seiji Kojima; Hitoshi Kanno; Kenzaburo Tani
Journal:  Exp Hematol       Date:  2019-03-12       Impact factor: 3.084

6.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.

Authors:  Lei Ye; Ying-Hua Chang; Qiang Xiong; Pengyuan Zhang; Liying Zhang; Porur Somasundaram; Mike Lepley; Cory Swingen; Liping Su; Jacqueline S Wendel; Jing Guo; Albert Jang; Daniel Rosenbush; Lucas Greder; James R Dutton; Jianhua Zhang; Timothy J Kamp; Dan S Kaufman; Ying Ge; Jianyi Zhang
Journal:  Cell Stem Cell       Date:  2014-12-04       Impact factor: 24.633

7.  Long-term expansion of alveolar stem cells derived from human iPS cells in organoids.

Authors:  Yuki Yamamoto; Shimpei Gotoh; Yohei Korogi; Masahide Seki; Satoshi Konishi; Satoshi Ikeo; Naoyuki Sone; Tadao Nagasaki; Hisako Matsumoto; Shigeo Muro; Isao Ito; Toyohiro Hirai; Takashi Kohno; Yutaka Suzuki; Michiaki Mishima
Journal:  Nat Methods       Date:  2017-10-02       Impact factor: 28.547

8.  Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.

Authors:  David A Knorr; Zhenya Ni; David Hermanson; Melinda K Hexum; Laura Bendzick; Laurence J N Cooper; Dean A Lee; Dan S Kaufman
Journal:  Stem Cells Transl Med       Date:  2013-03-20       Impact factor: 6.940

9.  Preparation of Induced Pluripotent Stem Cells Using Human Peripheral Blood Monocytes.

Authors:  Sumito Isogai; Naoki Yamamoto; Noriko Hiramatsu; Yasuhiro Goto; Masamichi Hayashi; Masashi Kondo; Kazuyoshi Imaizumi
Journal:  Cell Reprogram       Date:  2018-12       Impact factor: 1.987

10.  Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration.

Authors:  Zhouhui Geng; Patrick J Walsh; Vincent Truong; Caitlin Hill; Mara Ebeling; Rebecca J Kapphahn; Sandra R Montezuma; Ching Yuan; Heidi Roehrich; Deborah A Ferrington; James R Dutton
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

View more
  1 in total

1.  SigCom LINCS: data and metadata search engine for a million gene expression signatures.

Authors:  John Erol Evangelista; Daniel J B Clarke; Zhuorui Xie; Alexander Lachmann; Minji Jeon; Kerwin Chen; Kathleen M Jagodnik; Sherry L Jenkins; Maxim V Kuleshov; Megan L Wojciechowicz; Stephan C Schürer; Mario Medvedovic; Avi Ma'ayan
Journal:  Nucleic Acids Res       Date:  2022-05-07       Impact factor: 19.160

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.